Portal de Periódicos da CAPES

Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors

2015; American Society of Clinical Oncology; Volume: 11; Issue: 1 Linguagem: Inglês

10.1200/jop.2014.001492

1935-469X

Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov, Hairong Xu, Gary H. Lyman,

Blood disorders and treatments

Among patients receiving myelosuppressive chemotherapy for metastatic cancer in US clinical practice, febrile neutropenia is a frequent complication associated with morbidity, mortality, and economic costs.